Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 140, Issue 4, Pages 589-604
Publisher
Wiley
Online
2016-11-27
DOI
10.1111/jnc.13907
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nur77 inhibits oxLDL induced apoptosis of macrophages via the p38 MAPK signaling pathway
- (2016) Qin Shao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LLDT-8 protects against cerebral ischemia/reperfusion injury by suppressing post-stroke inflammation
- (2016) Yanke Chen et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation
- (2015) Jingshu Ni et al. BRAIN BEHAVIOR AND IMMUNITY
- Glia in mammalian development and disease
- (2015) J. Bradley Zuchero et al. DEVELOPMENT
- Nur77 deficiency leads to systemic inflammation in elderly mice
- (2015) Xiu-Ming Li et al. Journal of Inflammation-London
- Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation
- (2015) Zhuang Wu et al. JOURNAL OF NEUROCHEMISTRY
- Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation
- (2015) Li Li et al. Nature Chemical Biology
- Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
- (2015) Qinqin Wang et al. Translational Neurodegeneration
- Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages
- (2015) Anouk A. J. Hamers et al. PLoS One
- Antiinflammatory Effects of Orientin-2″-O-Galactopyranoside on Lipopolysaccharide-Stimulated Microglia
- (2014) Xiang Zhou et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- 1-O-Tigloyl-1-O-deacetyl-nimbolinin B Inhibits LPS-Stimulated Inflammatory Responses by Suppressing NF-κB and JNK Activation in Microglia Cells
- (2014) Li Tao et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Microglial priming in neurodegenerative disease
- (2014) V. Hugh Perry et al. Nature Reviews Neurology
- A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets
- (2013) Chenere P. Ramsey et al. EXPERIMENTAL NEUROLOGY
- Perturbation of Transcription FactorNur77Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
- (2013) Matthew P. Mount et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nur transcription factors in stress and addiction
- (2013) Danae Campos-Melo et al. Frontiers in Molecular Neuroscience
- A Unique Pharmacophore for Activation of the Nuclear Orphan Receptor Nur77 In vivo and In vitro
- (2010) Jing-jing Liu et al. CANCER RESEARCH
- NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection
- (2010) N. Volakakis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid
- (2009) Souha Mahmoudi et al. NEUROBIOLOGY OF DISEASE
- p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-κB pathway
- (2008) Su Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cytosporone B is an agonist for nuclear orphan receptor Nur77
- (2008) Yanyan Zhan et al. Nature Chemical Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started